A couple of references relevant for Pillar 3:
https://media.cellsignal.com/www/pdfs/science/pathways/m6a-rna.pdf
https://www.nature.com/articles/s41392-020-00450-x.pdf
Trying to work out:
For it to be meaningful for value (i.e. something concrete) in a transaction ... they must think they can hit the ground running.
- The other regulator proteins they will most likely target
- The non-cancer indications they will go after (to me key factors could be combination of unmet clinical need and market size)
- For #1, #2 is there low-hanging fruit driven by their existing collaborations with UoN, UoW, CoH?
- Opportunity size (tricky until we know more about #1, #2, #3)
![]()
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing & updated presentation
Ann: Race investor briefing & updated presentation, page-309
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.55 |
Change
-0.020(1.27%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.51 | $218.3K | 138.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 95 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 157 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 29100 | 1.500 |
1 | 353 | 1.470 |
2 | 3444 | 1.440 |
3 | 101000 | 1.420 |
4 | 14785 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.550 | 157 | 1 |
1.580 | 6715 | 2 |
1.600 | 2319 | 1 |
1.620 | 5327 | 1 |
1.630 | 1270 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |